Entrada Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Entrada Therapeutics Stock Summary

Entrada Therapeutics competes with Molecular Partners, Pmv Pharmaceuticals, Monte Rosa, Vigil Neuroscience, and Third Harmonic. Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle therapeutics for the treatment of multiple neuromuscular diseases. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Entrada Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Entrada Therapeutics Key Financial Ratios

Entrada Therapeutics Key Balance Sheet Accounts

Entrada Therapeutics Key Income Statement Accounts

Entrada Therapeutics Key Cash Accounts

Entrada Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Entrada Therapeutics's current stock value. Our valuation model uses many indicators to compare Entrada Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entrada Therapeutics competition to find correlations between indicators driving Entrada Therapeutics's intrinsic value. More Info.Entrada Therapeutics is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.30  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Entrada Therapeutics is roughly  3.32 . At present, Entrada Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Entrada Therapeutics' earnings, one of the primary drivers of an investment's value.

Entrada Therapeutics Systematic Risk

Today, most investors in Entrada Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Entrada Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Entrada Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Entrada Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Entrada Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Entrada Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Entrada Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Entrada Therapeutics's daily price indicators and compare them against related drivers.

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.